The Epidemiological Surveillance of Mesothelioma Mortality in Italy as a Tool for the Prevention of Asbestos Exposure.


Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
25 05 2023
Historique:
received: 23 03 2023
revised: 17 05 2023
accepted: 19 05 2023
medline: 12 6 2023
pubmed: 10 6 2023
entrez: 10 6 2023
Statut: epublish

Résumé

As part of a surveillance plan active since the early 1990s, this study evaluates malignant mesothelioma (MM) mortality for the time-window 2010-2019 in Italy, a country that banned asbestos in 1992. National and regional mortality rates for MM, and municipal standardized mortality ratios (all mesotheliomas, pleural (MPM) and peritoneal (MPeM)), by gender and age group were calculated. A municipal clustering analysis was also performed. There were 15,446 deaths from MM (11,161 males, 3.8 × 100,000; 4285 females, 1.1 × 100,000), of which 12,496 were MPM and 661 were MPeM. In the study period, 266 people ≤50 years died from MM. A slightly decreasing rate among males since 2014 was observed. The areas at major risk hosted asbestos-cement plants, asbestos mines (chrysotile in Balangero), shipyards, petrochemical and chemical plants, and refineries. Female mortality excesses particularly were found in municipalities with a fluoro-edenite-contaminated mine (Biancavilla) and textile facilities. Excesses were also found in a region with the presence of natural asbestos fibres and in males living in two small islands. The Italian National Prevention Plan stated recommendations to eliminate asbestos exposures and to implement health surveillance and healthcare for people exposed to asbestos.

Identifiants

pubmed: 37297561
pii: ijerph20115957
doi: 10.3390/ijerph20115957
pmc: PMC10252364
pii:
doi:

Substances chimiques

Asbestos 1332-21-4
Asbestos, Amphibole 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Am J Ind Med. 2013 Feb;56(2):133-45
pubmed: 22886909
Ann Ist Super Sanita. 2020 Oct-Dec;56(4):478-486
pubmed: 33346174
Occup Environ Med. 2017 Dec;74(12):887-898
pubmed: 28775133
Occup Environ Med. 2018 Dec;75(12):898-903
pubmed: 30158318
Epidemiol Prev. 2002 Nov-Dec;26(6):284-6
pubmed: 12619492
Cancer Epidemiol. 2019 Jun;60:162-167
pubmed: 31030080
Chest. 2007 Feb;131(2):376-82
pubmed: 17296636
Epidemiol Prev. 2023 Jan-Apr;47(1-2 Suppl 1):1-286
pubmed: 36825373
Eur J Epidemiol. 2003;18(2):171-4
pubmed: 12733840
Lancet. 2018 Nov 10;392(10159):1736-1788
pubmed: 30496103
Br J Cancer. 2009 Apr 7;100(7):1175-83
pubmed: 19259084
Ann N Y Acad Sci. 2006 Sep;1076:778-83
pubmed: 17119254
Ann Ist Super Sanita. 2014;50(2):133-8
pubmed: 24968911
Environ Res. 2020 Apr;183:108968
pubmed: 31812249
Occup Environ Med. 2018 Apr;75(4):254-262
pubmed: 29269563
Int J Environ Res Public Health. 2018 May 16;15(5):
pubmed: 29772681
Int J Environ Res Public Health. 2021 Sep 23;18(19):
pubmed: 34639316
J Environ Manage. 2022 Oct 1;319:115716
pubmed: 35863303
Int J Environ Res Public Health. 2020 Sep 21;17(18):
pubmed: 32967259
Environ Pollut. 2020 Aug;263(Pt B):114384
pubmed: 32234644
Int J Environ Res Public Health. 2020 Apr 12;17(8):
pubmed: 32290540
Environ Health Perspect. 2007 Oct;115(10):1401-5
pubmed: 17938727
Cancer Epidemiol. 2018 Aug;55:184-191
pubmed: 29990795
Int J Environ Res Public Health. 2023 Jan 04;20(2):
pubmed: 36673690
Epidemiol Prev. 2016 Sep-Oct;40(5Suppl1):99-104
pubmed: 27825199
Epidemiol Prev. 2021 Jul-Aug;45(4):289-295
pubmed: 34549571
Ann Epidemiol. 2011 Sep;21(9):688-97
pubmed: 21820631
Occup Environ Med. 2019 Jun;76(6):407-413
pubmed: 30804166
JAMA Oncol. 2022 Mar 01;8(3):420-444
pubmed: 34967848
Int J Environ Res Public Health. 2021 Dec 27;19(1):
pubmed: 35010531
Occup Environ Med. 2008 Dec;65(12):815-9
pubmed: 18524838
Environ Health. 2018 Dec 19;17(1):90
pubmed: 30567579
Int J Cancer. 2003 May 20;105(1):144-6
pubmed: 12672045
Environ Res. 2020 Sep;188:109691
pubmed: 32526494
Scand J Work Environ Health. 2004 Jun;30(3):249-52
pubmed: 15250654
Occup Environ Med. 2008 Mar;65(3):164-70
pubmed: 17704197
Int J Environ Res Public Health. 2021 Aug 09;18(16):
pubmed: 34444165
Am J Epidemiol. 2000 Feb 1;151(3):259-65
pubmed: 10670550
Int J Environ Res Public Health. 2021 Feb 12;18(4):
pubmed: 33673264
Public Health. 2021 Jun;195:57-60
pubmed: 34052509
Ann Transl Med. 2017 Jun;5(11):234
pubmed: 28706902
Cancers (Basel). 2021 Jul 03;13(13):
pubmed: 34283067
Occup Environ Med. 2017 Dec;74(12):851-858
pubmed: 28866609
Environ Health. 2021 Sep 15;20(1):103
pubmed: 34526026
Ochsner J. 2012 Spring;12(1):70-9
pubmed: 22438785
Ann Ist Super Sanita. 2011;47(3):296-304
pubmed: 21952156
Int J Environ Res Public Health. 2021 Jan 05;18(1):
pubmed: 33466544
Environ Health Perspect. 2001 Sep;109(9):915-9
pubmed: 11673120
Epidemiol Prev. 2018 Mar-Apr;42(2):142-150
pubmed: 29774711
Med Lav. 2011 Sep-Oct;102(5):409-16
pubmed: 22022760
Ann Ist Super Sanita. 2014;50(4):322-7
pubmed: 25522071
Arch Environ Health. 2003 Apr;58(4):229-32
pubmed: 14655903
Int J Environ Res Public Health. 2022 Feb 13;19(4):
pubmed: 35206274
Crit Rev Oncol Hematol. 2022 Nov;179:103821
pubmed: 36165817
New Solut. 2012;22(4):489-96
pubmed: 23380257
Int J Cancer. 2004 Oct 10;111(6):975-6
pubmed: 15300814

Auteurs

Lucia Fazzo (L)

Department of Environment and Health, Istituto Superiore di Sanità, 00161 Rome, Italy.

Giada Minelli (G)

Statistical Service, Istituto Superiore di Sanità, 00161 Rome, Italy.

Marco De Santis (M)

Department of Environment and Health, Istituto Superiore di Sanità, 00161 Rome, Italy.

Emiliano Ceccarelli (E)

Statistical Service, Istituto Superiore di Sanità, 00161 Rome, Italy.

Ivano Iavarone (I)

Department of Environment and Health, Istituto Superiore di Sanità, 00161 Rome, Italy.

Amerigo Zona (A)

Department of Environment and Health, Istituto Superiore di Sanità, 00161 Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH